Peetz Christopher bought ARQT
July 15, 2026 · Form 4 insider transaction
Peetz Christopher bought 4,315 shares of Arcutis Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,315
Price
$0.00
Total value
N/A
InsiderPeetz Christopher
RoleOfficer, Director
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 15, 2026
Filing dateJuly 17, 2026
Shares owned after4,315
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director of the Company. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of June 5, 2027, or immediately before the next annual meeting of stockholders, subject to the director's continued service through the vesting date.